Histogenics Corporation Announces First Quarter 2018 Financial and Operating Results
May 10, 2018 06:30 ET
|
Histogenics Corporation
‒ Top-line Superiority Data from NeoCart® Phase 3 Clinical Trial and Potential Biologics License Application Submission on Track for Third Quarter of 2018 ‒‒ Initiation of Phase 3 Clinical Trial in...
Histogenics Corporation to Report First Quarter 2018 Financial Results on May 10, 2018
April 26, 2018 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and...
Histogenics Corporation Announces the Appointment of Susan Washer to Its Board of Directors
April 18, 2018 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies (RCTs) that may offer rapid-onset...
Histogenics Corporation to Present at Upcoming Investor Conferences
March 28, 2018 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
Histogenics Corporation to Present at Needham & Company’s 17th Annual Healthcare Conference
March 19, 2018 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017
March 15, 2018 06:00 ET
|
Histogenics Corporation
NeoCart® Top-line Phase 3 Clinical Trial Data and Potential Biologics License Application Filing Remain on Track for Third Quarter of 2018 NeoCart Licensing Agreement with MEDINET Co. Ltd. Provides...
Histogenics to Showcase NeoCart® at American Academy of Orthopedic Surgeons and Orthopedic Research Society 2018 Annual Meetings
March 02, 2018 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., March 02, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
Histogenics Corporation to Report 2017 Financial Results on March 15, 2018
March 01, 2018 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and...
Histogenics Corporation to Present at Upcoming Investor Conferences
February 20, 2018 08:30 ET
|
Histogenics Corporation
WALTHAM, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
Histogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
January 25, 2018 16:05 ET
|
Histogenics Corporation
WALTHAM, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies, today announced the closing of its...